These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 24464391

  • 1. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, Kumita S.
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract] [Full Text] [Related]

  • 2. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.
    Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, Naya M, Committee for diagnosis of cardiac sarcoidosis using 18F-FDG PET, Japanese Society of Nuclear Cardiology.
    J Nucl Cardiol; 2019 Aug; 26(4):1414-1433. PubMed ID: 31197741
    [No Abstract] [Full Text] [Related]

  • 3. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
    Genovesi D, Bauckneht M, Altini C, Popescu CE, Ferro P, Monaco L, Borra A, Ferrari C, Caobelli F.
    Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
    [Abstract] [Full Text] [Related]

  • 4. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature.
    Sasson SC, Russo R, Chung T, Chu G, Hunyor I, Williamson J, Murad A, Kane A, Riminton S, Limaye S.
    J Med Case Rep; 2017 Oct 20; 11(1):291. PubMed ID: 29052526
    [Abstract] [Full Text] [Related]

  • 5. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC, Arrighi JA.
    J Nucl Cardiol; 2011 Apr 20; 18(2):371-4. PubMed ID: 21318450
    [No Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
    Györik S, Ceriani L, Menafoglio A, Gallino A, Wyttenbach R.
    Thorax; 2007 Jun 20; 62(6):560. PubMed ID: 17536038
    [No Abstract] [Full Text] [Related]

  • 7. Images in cardiology. Cardiac sarcoidosis in a 60 year old woman.
    Smedema JP, Reenaers V, Geukens R.
    Heart; 2006 May 20; 92(5):688. PubMed ID: 16614288
    [No Abstract] [Full Text] [Related]

  • 8. 18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis.
    Manabe O, Hirata K, Shozo O, Shiga T, Uchiyama Y, Kobayashi K, Watanabe S, Toyonaga T, Kikuchi H, Oyama-Manabe N, Tamaki N.
    J Nucl Cardiol; 2017 Feb 20; 24(1):329-331. PubMed ID: 27071998
    [Abstract] [Full Text] [Related]

  • 9. Advanced imaging of cardiac sarcoidosis.
    Schatka I, Bengel FM.
    J Nucl Med; 2014 Jan 20; 55(1):99-106. PubMed ID: 24232870
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic Value of PET in Cardiac Sarcoidosis.
    Smedema JP, van Kroonenburgh MJ, Snoep G, Bekkers SC, Gorgels AP.
    J Nucl Med; 2004 Nov 20; 45(11):1975. PubMed ID: 15534072
    [No Abstract] [Full Text] [Related]

  • 11. Sequential 18F-fluorodeoxyglucose positron emission tomography imaging in cardiac sarcoidosis.
    Sperry BW, Vuppala S.
    J Nucl Cardiol; 2024 May 20; 35():101860. PubMed ID: 38583507
    [No Abstract] [Full Text] [Related]

  • 12. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G, Jouni H, Acharya GA, Blauwet LA, Kapa S, Bois J, Chareonthaitawee P, Rodriguez-Porcel MG.
    J Nucl Cardiol; 2021 Apr 20; 28(2):661-671. PubMed ID: 31111450
    [Abstract] [Full Text] [Related]

  • 13. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H, Schulman AR, Dorbala S.
    Curr Cardiol Rep; 2013 May 20; 15(5):352. PubMed ID: 23504346
    [Abstract] [Full Text] [Related]

  • 14. Radionuclide Assessment of Sarcoidosis.
    Divakaran S.
    Cardiol Clin; 2023 May 20; 41(2):207-215. PubMed ID: 37003678
    [Abstract] [Full Text] [Related]

  • 15. Cardiac sarcoidosis: a challenge to measure disease activity.
    Keijsers RG, Verzijlbergen FJ, Rensing BJ, Grutters JC.
    J Nucl Cardiol; 2008 May 20; 15(4):595-8. PubMed ID: 18674727
    [No Abstract] [Full Text] [Related]

  • 16. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
    Ishimaru S, Tsujino I, Sakaue S, Oyama N, Takei T, Tsukamoto E, Tamaki N, Nishimura M.
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct 20; 22(3):234-5. PubMed ID: 16315788
    [No Abstract] [Full Text] [Related]

  • 17. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
    Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, Ito N, Ohira H, Ikeda D, Tamaki N, Nishimura M.
    Eur Heart J; 2005 Aug 20; 26(15):1538-43. PubMed ID: 15809286
    [Abstract] [Full Text] [Related]

  • 18. Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
    Miwa S, Inui N, Suda T, Miyazaki H, Torizuka T, Chida K.
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep 20; 24(2):156-8. PubMed ID: 18496990
    [No Abstract] [Full Text] [Related]

  • 19. Right ventricular mass: a rare presentation of cardiac sarcoidosis.
    Bertic M, Tandon S, Wisenberg G.
    Eur Heart J; 2016 Mar 14; 37(11):859. PubMed ID: 26705387
    [No Abstract] [Full Text] [Related]

  • 20. Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
    Koh AS, Kok TY, Sim DK, Lath N, Tan RS.
    Ann Acad Med Singap; 2014 Jul 14; 43(7):383-5. PubMed ID: 25142475
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.